Innate immunity and HIV-1 infection

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• HIV-1 primarily infects mucosal tissues, targeting CD4(+)CCR5(+) T cells, leading to rapid cell destruction.
• Conventional vaccines have failed to prevent HIV-1 infection due to insufficient early immune responses.
• Innate immunity provides a rapid, pathogen-independent defense mechanism crucial for early infection control.

Purpose of the Study:

• To review the role of innate immunity in early defense against HIV-1.
• To highlight cellular, extracellular, and intracellular components of innate immunity relevant to HIV-1.
• To explore the potential of innate immunity in preventing viral transmission or containing infection.

Main Methods:

• Review of existing literature on innate immune responses to HIV-1 and SIV.
• Examination of specific innate immune components: γδ T cells, CC chemokines (CCL-3, CCL-4, CCL-5), and APOBEC3G.
• Analysis of animal models (macaques) demonstrating innate immune responses following immunization.

Main Results:

• γδ T cells in mucosal tissues produce cytokines and antiviral factors.
• CC chemokines (CCL-3, CCL-4, CCL-5) can inhibit HIV-1 entry by downmodulating CCR5.
• APOBEC3G, an innate antiviral factor, is generated and maintained by CD4(+) T cells following mucosal immunization, linking innate immunity to immune memory.

Conclusions:

• Innate immunity components like γδ T cells, CC chemokines, and APOBEC3G play critical roles in early anti-HIV-1 defense.
• Innate immunity can inhibit viral entry and potentially prevent transmission or control the virus.
• The generation of APOBEC3G by CD4(+) T cells suggests a link between innate immunity and adaptive immune memory against HIV-1.